nodes	percent_of_prediction	percent_of_DWPC	metapath
Iohexol—Feeling abnormal—Bleomycin—testicular cancer	0.00243	0.00243	CcSEcCtD
Iohexol—Thrombophlebitis—Doxorubicin—testicular cancer	0.00243	0.00243	CcSEcCtD
Iohexol—Vomiting—Chlorambucil—testicular cancer	0.00242	0.00242	CcSEcCtD
Iohexol—Malaise—Cisplatin—testicular cancer	0.0024	0.0024	CcSEcCtD
Iohexol—Diarrhoea—Vinblastine—testicular cancer	0.00239	0.00239	CcSEcCtD
Iohexol—Dysgeusia—Etoposide—testicular cancer	0.00239	0.00239	CcSEcCtD
Iohexol—Hypotension—Ifosfamide—testicular cancer	0.00236	0.00236	CcSEcCtD
Iohexol—Pain—Dactinomycin—testicular cancer	0.00235	0.00235	CcSEcCtD
Iohexol—Anaphylactoid reaction—Epirubicin—testicular cancer	0.00235	0.00235	CcSEcCtD
Iohexol—Muscle spasms—Etoposide—testicular cancer	0.00235	0.00235	CcSEcCtD
Iohexol—Urticaria—Bleomycin—testicular cancer	0.00234	0.00234	CcSEcCtD
Iohexol—Body temperature increased—Bleomycin—testicular cancer	0.00233	0.00233	CcSEcCtD
Iohexol—Dizziness—Vinblastine—testicular cancer	0.00231	0.00231	CcSEcCtD
Iohexol—Convulsion—Cisplatin—testicular cancer	0.00231	0.00231	CcSEcCtD
Iohexol—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.0023	0.0023	CcSEcCtD
Iohexol—Pain in extremity—Epirubicin—testicular cancer	0.00227	0.00227	CcSEcCtD
Iohexol—Feeling abnormal—Dactinomycin—testicular cancer	0.00227	0.00227	CcSEcCtD
Iohexol—Nausea—Chlorambucil—testicular cancer	0.00227	0.00227	CcSEcCtD
Iohexol—Paraesthesia—Ifosfamide—testicular cancer	0.00227	0.00227	CcSEcCtD
Iohexol—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00225	0.00225	CcSEcCtD
Iohexol—Dyspnoea—Ifosfamide—testicular cancer	0.00225	0.00225	CcSEcCtD
Iohexol—Somnolence—Ifosfamide—testicular cancer	0.00224	0.00224	CcSEcCtD
Iohexol—Discomfort—Cisplatin—testicular cancer	0.00224	0.00224	CcSEcCtD
Iohexol—Vomiting—Vinblastine—testicular cancer	0.00222	0.00222	CcSEcCtD
Iohexol—Malaise—Etoposide—testicular cancer	0.0022	0.0022	CcSEcCtD
Iohexol—Headache—Vinblastine—testicular cancer	0.00219	0.00219	CcSEcCtD
Iohexol—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00218	0.00218	CcSEcCtD
Iohexol—Body temperature increased—Dactinomycin—testicular cancer	0.00218	0.00218	CcSEcCtD
Iohexol—Abdominal pain—Dactinomycin—testicular cancer	0.00218	0.00218	CcSEcCtD
Iohexol—Anaphylactic shock—Cisplatin—testicular cancer	0.00217	0.00217	CcSEcCtD
Iohexol—Hypersensitivity—Bleomycin—testicular cancer	0.00217	0.00217	CcSEcCtD
Iohexol—Anaphylactoid reaction—Doxorubicin—testicular cancer	0.00217	0.00217	CcSEcCtD
Iohexol—Cardiac arrest—Epirubicin—testicular cancer	0.00216	0.00216	CcSEcCtD
Iohexol—Pain—Ifosfamide—testicular cancer	0.00216	0.00216	CcSEcCtD
Iohexol—Loss of consciousness—Etoposide—testicular cancer	0.00215	0.00215	CcSEcCtD
Iohexol—Nervous system disorder—Cisplatin—testicular cancer	0.00213	0.00213	CcSEcCtD
Iohexol—Cough—Etoposide—testicular cancer	0.00213	0.00213	CcSEcCtD
Iohexol—Convulsion—Etoposide—testicular cancer	0.00211	0.00211	CcSEcCtD
Iohexol—Skin disorder—Cisplatin—testicular cancer	0.00211	0.00211	CcSEcCtD
Iohexol—Hypertension—Etoposide—testicular cancer	0.00211	0.00211	CcSEcCtD
Iohexol—Pain in extremity—Doxorubicin—testicular cancer	0.0021	0.0021	CcSEcCtD
Iohexol—Pruritus—Bleomycin—testicular cancer	0.00209	0.00209	CcSEcCtD
Iohexol—Feeling abnormal—Ifosfamide—testicular cancer	0.00208	0.00208	CcSEcCtD
Iohexol—Nausea—Vinblastine—testicular cancer	0.00208	0.00208	CcSEcCtD
Iohexol—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00206	0.00206	CcSEcCtD
Iohexol—Pancreatitis—Methotrexate—testicular cancer	0.00206	0.00206	CcSEcCtD
Iohexol—Discomfort—Etoposide—testicular cancer	0.00205	0.00205	CcSEcCtD
Iohexol—Hypotension—Cisplatin—testicular cancer	0.00203	0.00203	CcSEcCtD
Iohexol—Hypersensitivity—Dactinomycin—testicular cancer	0.00203	0.00203	CcSEcCtD
Iohexol—Confusional state—Etoposide—testicular cancer	0.00201	0.00201	CcSEcCtD
Iohexol—Muscular weakness—Epirubicin—testicular cancer	0.002	0.002	CcSEcCtD
Iohexol—Urticaria—Ifosfamide—testicular cancer	0.002	0.002	CcSEcCtD
Iohexol—Cardiac arrest—Doxorubicin—testicular cancer	0.002	0.002	CcSEcCtD
Iohexol—Body temperature increased—Ifosfamide—testicular cancer	0.00199	0.00199	CcSEcCtD
Iohexol—Abdominal pain—Ifosfamide—testicular cancer	0.00199	0.00199	CcSEcCtD
Iohexol—Anaphylactic shock—Etoposide—testicular cancer	0.00199	0.00199	CcSEcCtD
Iohexol—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.00198	0.00198	CcSEcCtD
Iohexol—Paraesthesia—Cisplatin—testicular cancer	0.00195	0.00195	CcSEcCtD
Iohexol—Dyspnoea—Cisplatin—testicular cancer	0.00194	0.00194	CcSEcCtD
Iohexol—Skin disorder—Etoposide—testicular cancer	0.00194	0.00194	CcSEcCtD
Iohexol—Pancreatitis—Epirubicin—testicular cancer	0.00193	0.00193	CcSEcCtD
Iohexol—Diarrhoea—Dactinomycin—testicular cancer	0.00188	0.00188	CcSEcCtD
Iohexol—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00188	0.00188	CcSEcCtD
Iohexol—Vomiting—Bleomycin—testicular cancer	0.00188	0.00188	CcSEcCtD
Iohexol—Hypotension—Etoposide—testicular cancer	0.00186	0.00186	CcSEcCtD
Iohexol—Rash—Bleomycin—testicular cancer	0.00186	0.00186	CcSEcCtD
Iohexol—Pain—Cisplatin—testicular cancer	0.00186	0.00186	CcSEcCtD
Iohexol—Dermatitis—Bleomycin—testicular cancer	0.00186	0.00186	CcSEcCtD
Iohexol—Hypersensitivity—Ifosfamide—testicular cancer	0.00186	0.00186	CcSEcCtD
Iohexol—Muscular weakness—Doxorubicin—testicular cancer	0.00185	0.00185	CcSEcCtD
Iohexol—Renal failure—Methotrexate—testicular cancer	0.00184	0.00184	CcSEcCtD
Iohexol—Feeling abnormal—Cisplatin—testicular cancer	0.00179	0.00179	CcSEcCtD
Iohexol—Paraesthesia—Etoposide—testicular cancer	0.00179	0.00179	CcSEcCtD
Iohexol—Pruritus—Ifosfamide—testicular cancer	0.00178	0.00178	CcSEcCtD
Iohexol—Pancreatitis—Doxorubicin—testicular cancer	0.00178	0.00178	CcSEcCtD
Iohexol—Dyspnoea—Etoposide—testicular cancer	0.00178	0.00178	CcSEcCtD
Iohexol—Somnolence—Etoposide—testicular cancer	0.00177	0.00177	CcSEcCtD
Iohexol—Nausea—Bleomycin—testicular cancer	0.00175	0.00175	CcSEcCtD
Iohexol—Vomiting—Dactinomycin—testicular cancer	0.00175	0.00175	CcSEcCtD
Iohexol—Rash—Dactinomycin—testicular cancer	0.00174	0.00174	CcSEcCtD
Iohexol—Diarrhoea—Ifosfamide—testicular cancer	0.00173	0.00173	CcSEcCtD
Iohexol—Renal failure—Epirubicin—testicular cancer	0.00172	0.00172	CcSEcCtD
Iohexol—Gastrointestinal disorder—Etoposide—testicular cancer	0.00172	0.00172	CcSEcCtD
Iohexol—Body temperature increased—Cisplatin—testicular cancer	0.00172	0.00172	CcSEcCtD
Iohexol—Pain—Etoposide—testicular cancer	0.0017	0.0017	CcSEcCtD
Iohexol—Dizziness—Ifosfamide—testicular cancer	0.00167	0.00167	CcSEcCtD
Iohexol—Urinary tract disorder—Methotrexate—testicular cancer	0.00166	0.00166	CcSEcCtD
Iohexol—Urethral disorder—Methotrexate—testicular cancer	0.00165	0.00165	CcSEcCtD
Iohexol—Feeling abnormal—Etoposide—testicular cancer	0.00164	0.00164	CcSEcCtD
Iohexol—Nausea—Dactinomycin—testicular cancer	0.00164	0.00164	CcSEcCtD
Iohexol—Gastrointestinal pain—Etoposide—testicular cancer	0.00163	0.00163	CcSEcCtD
Iohexol—Vomiting—Ifosfamide—testicular cancer	0.0016	0.0016	CcSEcCtD
Iohexol—Hypersensitivity—Cisplatin—testicular cancer	0.0016	0.0016	CcSEcCtD
Iohexol—Bradycardia—Epirubicin—testicular cancer	0.0016	0.0016	CcSEcCtD
Iohexol—Renal failure—Doxorubicin—testicular cancer	0.00159	0.00159	CcSEcCtD
Iohexol—Rash—Ifosfamide—testicular cancer	0.00159	0.00159	CcSEcCtD
Iohexol—Dermatitis—Ifosfamide—testicular cancer	0.00159	0.00159	CcSEcCtD
Iohexol—Urticaria—Etoposide—testicular cancer	0.00158	0.00158	CcSEcCtD
Iohexol—Body temperature increased—Etoposide—testicular cancer	0.00157	0.00157	CcSEcCtD
Iohexol—Abdominal pain—Etoposide—testicular cancer	0.00157	0.00157	CcSEcCtD
Iohexol—Eye disorder—Methotrexate—testicular cancer	0.00157	0.00157	CcSEcCtD
Iohexol—Cardiac disorder—Methotrexate—testicular cancer	0.00156	0.00156	CcSEcCtD
Iohexol—Urinary tract disorder—Epirubicin—testicular cancer	0.00155	0.00155	CcSEcCtD
Iohexol—Urethral disorder—Epirubicin—testicular cancer	0.00154	0.00154	CcSEcCtD
Iohexol—Angiopathy—Methotrexate—testicular cancer	0.00152	0.00152	CcSEcCtD
Iohexol—Immune system disorder—Methotrexate—testicular cancer	0.00152	0.00152	CcSEcCtD
Iohexol—Mediastinal disorder—Methotrexate—testicular cancer	0.00151	0.00151	CcSEcCtD
Iohexol—Nausea—Ifosfamide—testicular cancer	0.0015	0.0015	CcSEcCtD
Iohexol—Diarrhoea—Cisplatin—testicular cancer	0.00149	0.00149	CcSEcCtD
Iohexol—Bradycardia—Doxorubicin—testicular cancer	0.00148	0.00148	CcSEcCtD
Iohexol—Mental disorder—Methotrexate—testicular cancer	0.00147	0.00147	CcSEcCtD
Iohexol—Eye disorder—Epirubicin—testicular cancer	0.00147	0.00147	CcSEcCtD
Iohexol—Hypersensitivity—Etoposide—testicular cancer	0.00147	0.00147	CcSEcCtD
Iohexol—Erythema—Methotrexate—testicular cancer	0.00146	0.00146	CcSEcCtD
Iohexol—Flushing—Epirubicin—testicular cancer	0.00146	0.00146	CcSEcCtD
Iohexol—Cardiac disorder—Epirubicin—testicular cancer	0.00146	0.00146	CcSEcCtD
Iohexol—Urinary tract disorder—Doxorubicin—testicular cancer	0.00144	0.00144	CcSEcCtD
Iohexol—Dysgeusia—Methotrexate—testicular cancer	0.00143	0.00143	CcSEcCtD
Iohexol—Angiopathy—Epirubicin—testicular cancer	0.00143	0.00143	CcSEcCtD
Iohexol—Urethral disorder—Doxorubicin—testicular cancer	0.00143	0.00143	CcSEcCtD
Iohexol—Immune system disorder—Epirubicin—testicular cancer	0.00142	0.00142	CcSEcCtD
Iohexol—Mediastinal disorder—Epirubicin—testicular cancer	0.00142	0.00142	CcSEcCtD
Iohexol—Pruritus—Etoposide—testicular cancer	0.00141	0.00141	CcSEcCtD
Iohexol—Arrhythmia—Epirubicin—testicular cancer	0.0014	0.0014	CcSEcCtD
Iohexol—Vomiting—Cisplatin—testicular cancer	0.00138	0.00138	CcSEcCtD
Iohexol—Mental disorder—Epirubicin—testicular cancer	0.00138	0.00138	CcSEcCtD
Iohexol—Rash—Cisplatin—testicular cancer	0.00137	0.00137	CcSEcCtD
Iohexol—Dermatitis—Cisplatin—testicular cancer	0.00137	0.00137	CcSEcCtD
Iohexol—Erythema—Epirubicin—testicular cancer	0.00137	0.00137	CcSEcCtD
Iohexol—Diarrhoea—Etoposide—testicular cancer	0.00136	0.00136	CcSEcCtD
Iohexol—Eye disorder—Doxorubicin—testicular cancer	0.00136	0.00136	CcSEcCtD
Iohexol—Flushing—Doxorubicin—testicular cancer	0.00135	0.00135	CcSEcCtD
Iohexol—Cardiac disorder—Doxorubicin—testicular cancer	0.00135	0.00135	CcSEcCtD
Iohexol—Flatulence—Epirubicin—testicular cancer	0.00135	0.00135	CcSEcCtD
Iohexol—Dysgeusia—Epirubicin—testicular cancer	0.00134	0.00134	CcSEcCtD
Iohexol—Angiopathy—Doxorubicin—testicular cancer	0.00132	0.00132	CcSEcCtD
Iohexol—Malaise—Methotrexate—testicular cancer	0.00132	0.00132	CcSEcCtD
Iohexol—Dizziness—Etoposide—testicular cancer	0.00132	0.00132	CcSEcCtD
Iohexol—Muscle spasms—Epirubicin—testicular cancer	0.00132	0.00132	CcSEcCtD
Iohexol—Immune system disorder—Doxorubicin—testicular cancer	0.00131	0.00131	CcSEcCtD
Iohexol—Mediastinal disorder—Doxorubicin—testicular cancer	0.00131	0.00131	CcSEcCtD
Iohexol—Arrhythmia—Doxorubicin—testicular cancer	0.0013	0.0013	CcSEcCtD
Iohexol—Nausea—Cisplatin—testicular cancer	0.00129	0.00129	CcSEcCtD
Iohexol—Cough—Methotrexate—testicular cancer	0.00128	0.00128	CcSEcCtD
Iohexol—Mental disorder—Doxorubicin—testicular cancer	0.00127	0.00127	CcSEcCtD
Iohexol—Convulsion—Methotrexate—testicular cancer	0.00127	0.00127	CcSEcCtD
Iohexol—Vomiting—Etoposide—testicular cancer	0.00127	0.00127	CcSEcCtD
Iohexol—Erythema—Doxorubicin—testicular cancer	0.00127	0.00127	CcSEcCtD
Iohexol—Rash—Etoposide—testicular cancer	0.00126	0.00126	CcSEcCtD
Iohexol—Dermatitis—Etoposide—testicular cancer	0.00125	0.00125	CcSEcCtD
Iohexol—Headache—Etoposide—testicular cancer	0.00125	0.00125	CcSEcCtD
Iohexol—Flatulence—Doxorubicin—testicular cancer	0.00125	0.00125	CcSEcCtD
Iohexol—Arthralgia—Methotrexate—testicular cancer	0.00124	0.00124	CcSEcCtD
Iohexol—Dysgeusia—Doxorubicin—testicular cancer	0.00124	0.00124	CcSEcCtD
Iohexol—Malaise—Epirubicin—testicular cancer	0.00123	0.00123	CcSEcCtD
Iohexol—Discomfort—Methotrexate—testicular cancer	0.00123	0.00123	CcSEcCtD
Iohexol—Syncope—Epirubicin—testicular cancer	0.00123	0.00123	CcSEcCtD
Iohexol—Muscle spasms—Doxorubicin—testicular cancer	0.00122	0.00122	CcSEcCtD
Iohexol—Confusional state—Methotrexate—testicular cancer	0.0012	0.0012	CcSEcCtD
Iohexol—Loss of consciousness—Epirubicin—testicular cancer	0.0012	0.0012	CcSEcCtD
Iohexol—Cough—Epirubicin—testicular cancer	0.00119	0.00119	CcSEcCtD
Iohexol—Anaphylactic shock—Methotrexate—testicular cancer	0.00119	0.00119	CcSEcCtD
Iohexol—Convulsion—Epirubicin—testicular cancer	0.00119	0.00119	CcSEcCtD
Iohexol—Nausea—Etoposide—testicular cancer	0.00118	0.00118	CcSEcCtD
Iohexol—Hypertension—Epirubicin—testicular cancer	0.00118	0.00118	CcSEcCtD
Iohexol—Nervous system disorder—Methotrexate—testicular cancer	0.00117	0.00117	CcSEcCtD
Iohexol—Arthralgia—Epirubicin—testicular cancer	0.00116	0.00116	CcSEcCtD
Iohexol—Skin disorder—Methotrexate—testicular cancer	0.00116	0.00116	CcSEcCtD
Iohexol—Discomfort—Epirubicin—testicular cancer	0.00115	0.00115	CcSEcCtD
Iohexol—Malaise—Doxorubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Iohexol—Syncope—Doxorubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Iohexol—Confusional state—Epirubicin—testicular cancer	0.00113	0.00113	CcSEcCtD
Iohexol—Anaphylactic shock—Epirubicin—testicular cancer	0.00112	0.00112	CcSEcCtD
Iohexol—Hypotension—Methotrexate—testicular cancer	0.00112	0.00112	CcSEcCtD
Iohexol—Loss of consciousness—Doxorubicin—testicular cancer	0.00111	0.00111	CcSEcCtD
Iohexol—Cough—Doxorubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Iohexol—Shock—Epirubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Iohexol—Convulsion—Doxorubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Iohexol—Nervous system disorder—Epirubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Iohexol—Hypertension—Doxorubicin—testicular cancer	0.00109	0.00109	CcSEcCtD
Iohexol—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.00109	0.00109	CcSEcCtD
Iohexol—Skin disorder—Epirubicin—testicular cancer	0.00108	0.00108	CcSEcCtD
Iohexol—Arthralgia—Doxorubicin—testicular cancer	0.00108	0.00108	CcSEcCtD
Iohexol—Paraesthesia—Methotrexate—testicular cancer	0.00107	0.00107	CcSEcCtD
Iohexol—Discomfort—Doxorubicin—testicular cancer	0.00106	0.00106	CcSEcCtD
Iohexol—Dyspnoea—Methotrexate—testicular cancer	0.00106	0.00106	CcSEcCtD
Iohexol—Somnolence—Methotrexate—testicular cancer	0.00106	0.00106	CcSEcCtD
Iohexol—Hypotension—Epirubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Iohexol—Confusional state—Doxorubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Iohexol—Anaphylactic shock—Doxorubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Iohexol—Gastrointestinal disorder—Methotrexate—testicular cancer	0.00103	0.00103	CcSEcCtD
Iohexol—Pain—Methotrexate—testicular cancer	0.00102	0.00102	CcSEcCtD
Iohexol—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Iohexol—Shock—Doxorubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Iohexol—Nervous system disorder—Doxorubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Iohexol—Skin disorder—Doxorubicin—testicular cancer	0.001	0.001	CcSEcCtD
Iohexol—Paraesthesia—Epirubicin—testicular cancer	0.001	0.001	CcSEcCtD
Iohexol—Dyspnoea—Epirubicin—testicular cancer	0.000996	0.000996	CcSEcCtD
Iohexol—Somnolence—Epirubicin—testicular cancer	0.000993	0.000993	CcSEcCtD
Iohexol—Feeling abnormal—Methotrexate—testicular cancer	0.000983	0.000983	CcSEcCtD
Iohexol—Gastrointestinal pain—Methotrexate—testicular cancer	0.000976	0.000976	CcSEcCtD
Iohexol—Hypotension—Doxorubicin—testicular cancer	0.000966	0.000966	CcSEcCtD
Iohexol—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000964	0.000964	CcSEcCtD
Iohexol—Pain—Epirubicin—testicular cancer	0.000955	0.000955	CcSEcCtD
Iohexol—Urticaria—Methotrexate—testicular cancer	0.000948	0.000948	CcSEcCtD
Iohexol—Body temperature increased—Methotrexate—testicular cancer	0.000943	0.000943	CcSEcCtD
Iohexol—Abdominal pain—Methotrexate—testicular cancer	0.000943	0.000943	CcSEcCtD
Iohexol—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000941	0.000941	CcSEcCtD
Iohexol—Paraesthesia—Doxorubicin—testicular cancer	0.000928	0.000928	CcSEcCtD
Iohexol—Dyspnoea—Doxorubicin—testicular cancer	0.000921	0.000921	CcSEcCtD
Iohexol—Feeling abnormal—Epirubicin—testicular cancer	0.00092	0.00092	CcSEcCtD
Iohexol—Somnolence—Doxorubicin—testicular cancer	0.000919	0.000919	CcSEcCtD
Iohexol—Gastrointestinal pain—Epirubicin—testicular cancer	0.000913	0.000913	CcSEcCtD
Iohexol—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000892	0.000892	CcSEcCtD
Iohexol—Urticaria—Epirubicin—testicular cancer	0.000887	0.000887	CcSEcCtD
Iohexol—Pain—Doxorubicin—testicular cancer	0.000884	0.000884	CcSEcCtD
Iohexol—Abdominal pain—Epirubicin—testicular cancer	0.000883	0.000883	CcSEcCtD
Iohexol—Body temperature increased—Epirubicin—testicular cancer	0.000883	0.000883	CcSEcCtD
Iohexol—Hypersensitivity—Methotrexate—testicular cancer	0.000879	0.000879	CcSEcCtD
Iohexol—Feeling abnormal—Doxorubicin—testicular cancer	0.000851	0.000851	CcSEcCtD
Iohexol—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000845	0.000845	CcSEcCtD
Iohexol—Pruritus—Methotrexate—testicular cancer	0.000844	0.000844	CcSEcCtD
Iohexol—Hypersensitivity—Epirubicin—testicular cancer	0.000823	0.000823	CcSEcCtD
Iohexol—Urticaria—Doxorubicin—testicular cancer	0.000821	0.000821	CcSEcCtD
Iohexol—Abdominal pain—Doxorubicin—testicular cancer	0.000817	0.000817	CcSEcCtD
Iohexol—Body temperature increased—Doxorubicin—testicular cancer	0.000817	0.000817	CcSEcCtD
Iohexol—Diarrhoea—Methotrexate—testicular cancer	0.000816	0.000816	CcSEcCtD
Iohexol—Pruritus—Epirubicin—testicular cancer	0.00079	0.00079	CcSEcCtD
Iohexol—Dizziness—Methotrexate—testicular cancer	0.000789	0.000789	CcSEcCtD
Iohexol—Diarrhoea—Epirubicin—testicular cancer	0.000764	0.000764	CcSEcCtD
Iohexol—Hypersensitivity—Doxorubicin—testicular cancer	0.000761	0.000761	CcSEcCtD
Iohexol—Vomiting—Methotrexate—testicular cancer	0.000759	0.000759	CcSEcCtD
Iohexol—Rash—Methotrexate—testicular cancer	0.000752	0.000752	CcSEcCtD
Iohexol—Dermatitis—Methotrexate—testicular cancer	0.000752	0.000752	CcSEcCtD
Iohexol—Headache—Methotrexate—testicular cancer	0.000748	0.000748	CcSEcCtD
Iohexol—Dizziness—Epirubicin—testicular cancer	0.000738	0.000738	CcSEcCtD
Iohexol—Pruritus—Doxorubicin—testicular cancer	0.000731	0.000731	CcSEcCtD
Iohexol—Vomiting—Epirubicin—testicular cancer	0.00071	0.00071	CcSEcCtD
Iohexol—Nausea—Methotrexate—testicular cancer	0.000709	0.000709	CcSEcCtD
Iohexol—Diarrhoea—Doxorubicin—testicular cancer	0.000707	0.000707	CcSEcCtD
Iohexol—Rash—Epirubicin—testicular cancer	0.000704	0.000704	CcSEcCtD
Iohexol—Dermatitis—Epirubicin—testicular cancer	0.000703	0.000703	CcSEcCtD
Iohexol—Headache—Epirubicin—testicular cancer	0.0007	0.0007	CcSEcCtD
Iohexol—Dizziness—Doxorubicin—testicular cancer	0.000683	0.000683	CcSEcCtD
Iohexol—Nausea—Epirubicin—testicular cancer	0.000663	0.000663	CcSEcCtD
Iohexol—Vomiting—Doxorubicin—testicular cancer	0.000657	0.000657	CcSEcCtD
Iohexol—Rash—Doxorubicin—testicular cancer	0.000652	0.000652	CcSEcCtD
Iohexol—Dermatitis—Doxorubicin—testicular cancer	0.000651	0.000651	CcSEcCtD
Iohexol—Headache—Doxorubicin—testicular cancer	0.000647	0.000647	CcSEcCtD
Iohexol—Nausea—Doxorubicin—testicular cancer	0.000614	0.000614	CcSEcCtD
